Hyperprogression Emerges in a Subset of Patients Treated With Immunotherapy – OncLive
OncLive |
Hyperprogression Emerges in a Subset of Patients Treated With Immunotherapy
OncLive The extent of hyperprogressive disease (HPD) after immunotherapy treatment has not been fully characterized, but evidence continues to build that it may not be as rare of a phenomenon as previously thought. Results from a recent multicenter … |
